Academics from Aston University’s School of Life and Health Sciences, led by Peter Lambert, Professor of Microbiology, have embarked on a collaboration with Mologic Limited, with scientists from the University Hospital Birmingham NHS Foundation Trust to develop a simple, inexpensive, effective, point of care immunodiagnostic system for early confirmation of sepsis in at-risk patients.
Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.
Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.